Antimicrobial Resistance (AMR) Study
Launched by UNIVERSITY OF ALEPPO · Apr 17, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Antimicrobial Resistance (AMR) Study is a clinical trial that aims to understand how healthcare workers in Syria think about and use antibiotics. Antibiotics are medicines that help treat infections, but using them incorrectly can lead to a problem called antibiotic resistance, where these medicines become less effective. The study will gather information through questionnaires to learn more about healthcare workers' knowledge, attitudes, and behaviors related to antibiotic use.
To participate in this study, you need to be a healthcare worker, either male or female, aged between 25 and 65 years or older. If you agree to take part, you will fill out a questionnaire, which is a set of questions about your experiences and views. This is a great opportunity to contribute to important research that could help improve how antibiotics are used and reduce resistance in the future.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: We include healthcare workers, males or females aged 25 to over 65.
- • -
- • Exclusion Criteria: Participants who do not agree to fill the questionnaire, who do not agree to fill all requested questions, and who filled the questionnaire before.
- • -
About University Of Aleppo
The University of Aleppo is a prestigious educational and research institution located in Aleppo, Syria, dedicated to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and advancing healthcare practices. The institution is committed to upholding ethical standards and regulatory compliance in its clinical studies, fostering collaboration with national and international partners to contribute valuable insights to the medical community and enhance the overall quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aleppo, , Syrian Arab Republic
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported